Početna › Akutna bifentipska leukemija › West Virginia
Kliničke studije za Akutna bifentipska leukemija u državi West Virginia
3 studija za Akutna bifentipska leukemija traži sudionike na lokacijama u državi West Virginia.
Službeni tekst studije (engleski)
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- West Virginia University Charleston Division, Charleston
U tijeku regrutacijaFaza 3
365 Days – 25 Years · Oba spola · Ažurirano 25. kol 2026. · NCT03959085The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- West Virginia University Healthcare, Morgantown
U tijeku regrutacijaFaza 1/2
Do 22 godina · Oba spola · Ažurirano 25. kol 2026. · NCT04726241Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)
- West Virginia University Cancer Institute, Morgantown
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 13. tra 2026. · NCT07222579Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.